Catalyst Wire Dossier Catalyst Wire Dossier

Levofloxacin in 5% dextrose

Levofloxacin in 5% dextrose · Eugia US LLC
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Levofloxacin in 5% dextrose, covering 2016-02-10 to 2024-09-20. Get the full timeline:

Most recent: FDA Approved: LEVOFLOXACIN — Supplemental Application (Eugia US LLC)

See pricing